immuno-onco modulatory progenitor cell therapy (Celixir)

N/A

Report date: 2025/03/20 15:01:49

Base Information

Drug Nameimmuno-onco modulatory progenitor cell therapy (Celixir)
Drug Alias NameiOMP stem cell therapy (Celixir)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionStem cells modulatorsImmunostimulants
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCelixir
China Registration ClassN/A

Develop Information

Active CompaniesCelixir
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A